Evaluation of the 5-HT 2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction.

Joanna Jastrzębska Małgorzata Frankowska Irena Smaga Magdalena Hubalewska-MazgajAgata SuderRenata PieniążekEdmund Przegaliński Małgorzata Filip

Published in: Pharmacological reports : PR (2022)

receptors for treating CUD and comorbid depression and CUD. They may be backs the further research of pharmacological strategies with drug targeting receptors.

Keyphrases

depressive symptoms
sleep quality
cancer therapy
cell therapy
stem cells
bone marrow